Furthermore, the Outsourcing Facilities Association has sued the FDA, claiming the removal of semaglutide from the shortage list is arbitrary and capricious because there are still risks of supply shortages
However, it's essential to understand what you're purchasing and that it is not the same as a brand-name FDA-approved medication
This is important to note moving forward, particularly with the prevalence of GLP-1 use extending beyond T2DM now
18 The remaining warning letters went to six finished prescription drug manufacturers and nine API manufacturers
Astrocytes are converted from a resting form to a reactive form by activated microglia secreting IL-1, TNF-, and C1q, contributing to neurodegenerative diseases like AD and Parkinsons disease (PD) [50]
But we need to strike a balance between these (and other) risks and the benefits of GLP-1 medications in diabetes care, obesity treatment, reducing heart attack risks and extending lives